Home > Insider Trading > Filing (0001179110-14-005253)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1274057	Hospira Inc	HSP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1574982	R Matthew Stober	C/O Hospira, Inc. 275 North Field Drive Lake Forest IL 60045	Svp, Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-03-14	4,990	$35.36	62,353	No	4	M	Direct
Common Stock	Disposition	2014-03-14	4,290	$42.30	58,063	No	4	S	Direct
Common Stock	Disposition	2014-03-14	400	$42.32	57,663	No	4	S	Direct
Common Stock	Disposition	2014-03-14	300	$42.33	57,363	No	4	S	Direct
Common Stock	Acquisiton	2014-03-14	14,227	$28.95	71,590	No	4	M	Direct
Common Stock	Disposition	2014-03-14	4,300	$42.25	67,290	No	4	S	Direct
Common Stock	Disposition	2014-03-14	2,022	$42.27	65,268	No	4	S	Direct
Common Stock	Disposition	2014-03-14	6,300	$42.28	58,968	No	4	S	Direct
Common Stock	Disposition	2014-03-14	1,505	$42.29	57,463	No	4	S	Direct
Common Stock	Disposition	2014-03-14	100	$42.29	57,363	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to buy)	Disposition	2014-03-14	4,990	$0.00	4,990	$35.36
Common Stock	Stock Options (Right to buy)	Disposition	2014-03-14	14,227	$0.00	14,227	$28.95

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,980		2019-02-28	No	4	M	Direct
42,684		2020-02-26	No	4	M	Direct

Footnotes

These exercised options (which were part of a grant on March 1, 2012 that fully vests over four years) vested on March 1, 2014 and are fully exercisable. The remaining unvested options vest in two equal annual increments on March 1, 2015 and 2016.
These exercised options (which were part of a grant on February 28, 2013 that fully vests over three years) vested on February 27, 2014 and are fully exercisable. The remaining unvested options vest in two equal annual increments on February 27, 2015 and 2016.